Polyglutamine expansion in ataxin-3 does not affect protein stability - Implications for misfolding and disease

被引:61
|
作者
Chow, MKM [1 ]
Ellisdon, AM [1 ]
Cabrita, LD [1 ]
Bottomley, SP [1 ]
机构
[1] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia
关键词
D O I
10.1074/jbc.M405799200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polyglutamine proteins that cause neurodegenerative disease are known to form proteinaceous aggregates, such as nuclear inclusions, in the neurons of affected patients. Although polyglutamine proteins have been shown to form fibrillar aggregates in a variety of contexts, the mechanisms underlying the aberrant conformational changes and aggregation are still not well understood. In this study, we have investigated the hypothesis that polyglutamine expansion in the protein ataxin-3 destabilizes the native protein, leading to the accumulation of a partially unfolded, aggregation-prone intermediate. To examine the relationship between polyglutamine length and native state stability, we produced and analyzed three ataxin-3 variants containing 15, 28, and 50 residues in their respective glutamine tracts. At pH 7.4 and 37degreesC, Atax3(Q50), which lies within the pathological range, formed fibrils significantly faster than the other proteins. Somewhat surprisingly, we observed no difference in the acid-induced equilibrium and kinetic un/folding transitions of all three proteins, which indicates that the stability of the native conformation was not affected by polyglutamine tract extension. This has led us to reconsider the mechanisms and factors involved in ataxin-3 misfolding, and we have developed a new model for the aggregation process in which the pathways of un/folding and misfolding are distinct and separate. Furthermore, given that native state stability is unaffected by polyglutamine length, we consider the possible role and influence of other factors in the fibrillization of ataxin-3.
引用
收藏
页码:47643 / 47651
页数:9
相关论文
共 50 条
  • [1] Mechanisms of ataxin-3 misfolding and fibril formation: Kinetic analysis of a disease-associated polyglutamine protein
    Ellisdon, Andrew M.
    Pearce, Mary C.
    Bottomley, Stephen P.
    JOURNAL OF MOLECULAR BIOLOGY, 2007, 368 (02) : 595 - 605
  • [2] Alternative splicing of Ataxin-3, a polyglutamine (polyQ) disease protein
    Harris, Ginny Marie
    Dodelzon, Katerina
    Paulson, Henry L.
    FASEB JOURNAL, 2007, 21 (06): : A1274 - A1274
  • [3] Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3
    Berke, SJS
    Schmied, FAF
    Brunt, ER
    Ellerby, LM
    Paulson, HL
    JOURNAL OF NEUROCHEMISTRY, 2004, 89 (04) : 908 - 918
  • [4] SUMO-1 promotes degradation of the polyglutamine disease protein ataxin-3
    Jung, Na Ri
    Lee, Do Hee
    ANIMAL CELLS AND SYSTEMS, 2013, 17 (01) : 7 - 14
  • [5] p45 targets the polyglutamine disease protein ataxin-3 to the proteasome
    Wang, Hongfeng
    Jia, Nali
    Fei, Erkang
    Wang, Zhiming
    Liu, Chao
    Zhang, Tao
    Fan, Jun
    Wu, Mian
    Chen, Lin
    Nukina, Nobuyuki
    Zhou, Jiangning
    Wang, Guanghui
    NEUROSCIENCE RESEARCH, 2007, 58 : S121 - S121
  • [6] Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3
    Berke, SJS
    Chai, YH
    Marrs, GL
    Wen, H
    Paulson, HL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (36) : 32026 - 32034
  • [7] Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3
    Costa, Maria do Carmo
    Ashraf, Naila S.
    Fischer, Svetlana
    Yang, Yemen
    Schapka, Emily
    Joshi, Gnanada
    McQuade, Thomas J.
    Dharia, Rahil M.
    Dulchavsky, Mark
    Ouyang, Michelle
    Cook, David
    Sun, Duxin
    Larsen, Martha J.
    Gestwicki, Jason E.
    Todi, Sokol V.
    Ivanova, Magdalena I.
    Paulson, Henry L.
    BRAIN, 2016, 139 : 2891 - 2908
  • [8] Ubiquitination of the polyglutamine disease protein ataxin-3 enhances its activity as a deubiquitinating enzyme
    Todi, Sokol V.
    Winborn, Brett J.
    Williams, Aislinn J.
    Paulson, Henry L.
    FASEB JOURNAL, 2008, 22
  • [9] The polyglutamine-expanded protein ataxin-3 decreases bcl-2 mRNA stability
    Tien, Chih-Liang
    Wen, Feng-Chen
    Hsieh, Mingli
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 365 (02) : 232 - 238
  • [10] Cellular turnover of the polyglutamine disease protein ataxin-3 is regulated by its catalytic activity
    Todi, Sokol V.
    Laco, Mario N.
    Winborn, Brett J.
    Travis, Sue M.
    Wen, Hsiang M.
    Paulson, Henry L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (40) : 29348 - 29358